A new predictive tool for postoperative radiotherapy in prostate cancer
- PMID: 28418285
- PMCID: PMC5499754
- DOI: 10.1080/15384047.2017.1310347
A new predictive tool for postoperative radiotherapy in prostate cancer
Abstract
The standard treatments of localized prostate cancer include surgical resection and/or radiotherapy. Recently in 2016, Zhao et al. described a tool to predict which patients will most likely gain from postoperative radiotherapy. Such a method can personalize treatment plan by maximizing benefit but minimizing harm.
Keywords: Predictive tool; prostate cancer; radiotherapy.
Comment on
-
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.Lancet Oncol. 2016 Nov;17(11):1612-1620. doi: 10.1016/S1470-2045(16)30491-0. Epub 2016 Oct 12. Lancet Oncol. 2016. PMID: 27743920
References
-
- Sharma S, Zapatero-Rodriguez J, O'Kennedy R. Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools. Biotechnol Adv 2016; 35:135–49; PMID:27939303; https://doi.org/10.1016/j.biotechadv.2016.11.009 - DOI - PubMed
-
- Kwon O, Kim KB, Lee YI, Byun SS, Kim JS, Lee SE, Hong SK. Salvage radiotherapy after radical prostatectomy: prediction of biochemical outcomes. PLoS One 2014; 9(7):e103574; PMID:25072938; https://doi.org/ 10.1371/journal.pone.0103574 - DOI - PMC - PubMed
-
- Bartkowiak D, Bottke D, Wiegel T. Radiotherapy in the management of prostate cancer after radical prostatectomy. Future Oncol 2013; 9(5):669-79; PMID:23647296; https://doi.org/ 10.2217/fon.13.3 - DOI - PubMed
-
- Darwish OM, Raj GV. Management of biochemical recurrence after primary localized therapy for prostate cancer. Front Oncol 2012; 2:48; PMID:22655274; https://doi.org/ 10.3389/fonc.2012.00048 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical